Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT07527819Not Yet Recruiting

Evaluating Ovarian Toxicity Outcomes Following Immunotherapy in Patients With Triple-Negative Breast Cancer (TNBC)

Role: collaborator

NCT05349058Unknown

Assessment of Myocardial Injury in Patients Treated With Immune Checkpoint Inhibitors

Role: collaborator

NCT03035136Completed

Retrospective Study on Epidemiology of Colorectal Lesions

Role: lead

NCT01551160Not ApplicableCompleted

Impact of a Communication and Team-working Intervention on Performance and Effectiveness of a Medical Emergency Team

Role: lead

NCT02963207Not ApplicableCompleted

MS Versus NICE for Colorectal Lesions

Role: lead

NCT01985347Not ApplicableUnknown

The SAD Study - SLEEP, ANXIETY & DEPRESSION Study A Prospective Cohort Study

Role: collaborator

All 6 trials loaded